tiprankstipranks
Kala Pharmaceuticals Inc (KALA)
NASDAQ:KALA
US Market

Kala Pharmaceuticals (KALA) Income Statement

Compare
1,451 Followers

Kala Pharmaceuticals Income Statement

Last quarter (Q3 2024), Kala Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Kala Pharmaceuticals's net income was $-8.95M. See Kala Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 3.89M$ 11.24M$ 6.36M$ 6.07M
Gross Profit
$ -303.00K$ 1.33M$ 7.14M$ 3.19M$ 4.07M
Operating Expenses
$ 38.85M$ 82.69M$ 116.58M$ 99.42M$ 92.29M
Depreciation and Amortization
$ 303.00K$ 860.00K$ 2.27M$ 2.84M$ 2.62M
EBITDA
$ -36.08M$ -36.70M$ -131.96M$ -92.90M$ -83.25M
Operating Income
$ -39.15M$ -81.36M$ -109.43M$ -96.23M$ -88.22M
Other Income/Expenses
$ -3.05M$ 36.53M$ -12.36M$ -8.10M$ -6.12M
Pretax Income
$ -42.20M$ -44.82M$ -142.60M$ -104.33M$ -94.35M
Net Income
$ -42.20M$ -223.00K$ -152.30M$ -112.00M$ -101.98M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -17.35$ -0.15$ -116.79$ -106.92$ -149.06
Diluted EPS
$ -17.35$ -0.15$ -116.79$ -106.92$ -149.06
Weighted Average Shares Outstanding
2.43M 1.52M 1.30M 1.05M 684.20K
Weighted Average Shares Outstanding (Diluted)
2.43M 1.52M 1.30M 1.05M 684.20K
Currency in USD

Kala Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis